Impact of Cultural and Linguistic Factors on Symptom Reporting by Patients With Cancer

Department of Symptom Research, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1450, Houston, TX 77030, USA.
Journal of the National Cancer Institute (Impact Factor: 12.58). 03/2010; 102(10):732-8. DOI: 10.1093/jnci/djq097
Source: PubMed


Patient reporting of the severity and impact of symptoms is an essential component of cancer symptom management and cancer treatment clinical trials. In multinational clinical trials, cultural and linguistic variations in patient-reported outcomes instruments could confound the interpretation of study results.
The severity and interference of multiple symptoms in 1433 cancer patients with mixed diagnoses and treatment status from the United States, China, Japan, Russia, and Korea were measured with psychometrically validated language versions of the M. D. Anderson Symptom Inventory (MDASI). Mixed-effect ordinal probit regression models were fitted to the pooled data to compare the magnitude of the effect of "country" (nation and linguistic factors) with between-subjects effects on symptom reporting, adjusted for patient and clinical factors (age, sex, performance status, and chemotherapy status).
For the pooled sample, fatigue, disturbed sleep, distress, pain, and lack of appetite were the most severe patient-reported MDASI symptoms. The magnitude of the variance of the country random effects was only one-fourth to one-half of the interpatient variation (sigma(2) = 0.23-0.46) for all symptoms, except nausea and vomiting.
Cultural and linguistic variations in symptom reporting among the five language versions of the validated MDASI were limited. Ordinal probit modeling provided a simple mechanism for accounting for cultural and linguistic differences in patient populations. The equivalence among MDASI translations in this study suggests that symptom ratings collected from various cultural and language groups using the MDASI can be interpreted in a similar way in oncology practice, clinical trials, and clinical research.

Download full-text


Available from: Toru Okuyama,
22 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Titanium and chromium arc discharges in nitrogen and argon in the pressure range between 10<sup>-3</sup> and 1 Pa have been studied using optical emission spectroscopy and electric probes. The pressure dependence of normalized line intensities could be explained in terms of the metal vapor generation at the cathode as well as ion-molecule collisions in the arc plasma far from the cathode. Obviously, inelastic electron collisions do not play a decisive role. The excited levels of metal species were found to be populated according to a Boltzmann distribution. An excitation temperature of about 0.3 eV was calculated for the neutrals, whereas the excitation temperature of ions was somewhat higher. The degree of vibrational excitation of various electronic states of the N<sub>2</sub> molecule was found to be nearly the same in Cr and Ti are discharges, respectively. The main result of the present study was that the excitation degree of chromium and titanium are discharges in argon and nitrogen, respectively, is similar
    IEEE Transactions on Plasma Science 09/1997; 25(4-25):694 - 699. DOI:10.1109/27.640688 · 1.10 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Few studies have investigated the prevalence of the unmet needs among advanced or recurrent breast cancer patients in Asian countries and little is known about the relation between their unmet needs and psychological distress/quality of life. The participants (n = 87) comprised randomly selected ambulatory female patients with advanced or recurrent breast cancer attending the Outpatient Department of Oncology, Immunology and Surgery of Nagoya City University Hospital. The patients were asked to complete self-administered questionnaires assessing the level of their physical and psychological symptoms, supportive care needs and socio-demographic and biomedical factors. The association between the patients' perceived needs and psychological distress/quality of life was then analyzed statistically. The patients had a mean ± standard deviation of 11 ± 7.7 and a median of 10 unmet needs. The prevalence of the 17 most frequent unmet needs was over 50%, and almost all of these unmet need items belonged to the Psychological or the Health system and information domain. The total Short-form Supportive Care Needs Survey Questionnaire with cancer score was significantly associated with the indices of psychological distress and quality of life. Most of the Short-form Supportive Care Needs Survey Questionnaire with cancer domains except Sexuality domain were also significantly associated with all the indices of psychological distress. Psychosocial needs were strongly associated with psychological distress and quality of life. Quality of life and psychological distress may be improved if interventions for unmet needs, especially psychological and information needs, are made.
    Japanese Journal of Clinical Oncology 12/2010; 41(4):530-6. DOI:10.1093/jjco/hyq230 · 2.02 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We conducted a study to establish the psychometric properties of a module of the M. D. Anderson Symptom Inventory (MDASI) developed specifically for patients with lung cancer (MDASI-LC). The MDASI measures 13 common "core" symptoms of cancer and its treatment. The MDASI-LC includes the 13 core MDASI symptom items and three lung cancer-specific items: coughing, constipation, and sore throat. MDASI-LC items were administered to three cohorts of patients with lung cancer undergoing either chemotherapy or chemoradiotherapy. Known-group validity and criterion (concurrent) validity of the MDASI-LC were evaluated using the Eastern Cooperative Oncology Group performance status and the 12-item Short-Form Health Survey. The internal consistency and test-retest reliability of the module were adequate, with Cronbach coefficient α-values of 0.83 or higher for all module items and subscales. The sensitivity of the MDASI-LC to changes in patient performance status (disease progression) and to continuing cancer treatment (effects of treatment) was established. Cognitive debriefing of a subset of participants provided evidence for content validity and indicated that the MDASI core items and three additional lung cancer-specific items were clear, relevant to patients, and easy to understand; only two patients suggested additional symptom items. As expected, the item "sore throat" was sensitive only for patients receiving chemoradiotherapy. The MDASI-LC is a valid, reliable, and sensitive symptom-assessment instrument whose use can enhance clinical studies of symptom status in patients with lung cancer and epidemiological and prevalence studies of symptom severity across various cancer types.
    The Oncologist 02/2011; 16(2):217-27. DOI:10.1634/theoncologist.2010-0193 · 4.87 Impact Factor
Show more